Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study (Q36975695)
Jump to navigation
Jump to search
scientific article published on 22 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study |
scientific article published on 22 September 2008 |
Statements
1 reference
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study (English)
1 reference
Ralph A DeFronzo
1 reference
Penny R Fleck
1 reference
Craig A Wilson
1 reference
Qais Mekki
1 reference
Alogliptin Study 010 Group
1 reference
22 September 2008
1 reference
Identifiers
1 reference